Dopamine dysfunction in AD/HD: Integrating clinical and basic neuroscience research

Behavioural Brain Research

Volumn 130, Issue 1-2, 2002, Pages 65-71

  Solanto, Mary V ^a  

^a MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

Amphetamine; Attention; Attention deficit hyperactivity disorder (ADHD); Autoreceptors; Dopamine; Dopamine transporter (DAT); fMRI; Impulsivity; Methylphenidate; MRI; PET; Prefrontal cortex; Prefrontal striatal thalamic cortical circuit; Rate dependency; Striatum

Indexed keywords

CATECHOLAMINE DERIVATIVE; CENTRAL STIMULANT AGENT; DESIPRAMINE; DEXAMPHETAMINE; DOPAMINE; DROPERIDOL; METHYLPHENIDATE; NEUROLEPTIC AGENT; NORADRENALIN; RACLOPRIDE;

ATTENTION; ATTENTION DEFICIT DISORDER; BEHAVIOR; BRAIN METABOLISM; CLINICAL RESEARCH; COGNITION; CONFERENCE PAPER; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG MECHANISM; HUMAN; HYPERACTIVITY; IMPULSIVENESS; MOTOR ACTIVITY; NEUROTRANSMISSION; NONHUMAN; NORADRENERGIC SYSTEM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SYMPTOMATOLOGY; WORKING MEMORY;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; COGNITION; DOPAMINE; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 0037051154     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(01)00431-4     Document Type: Conference Paper

References (76)

1. Parallel organization of functionally segregated circuits linking the basal ganglia and cortex
2. Catecholamine regulation of the prefrontal cortex
3. Dopaminergic and noradrenergic influences on cognitive functions mediated by prefrontal cortex
4. Frontal lobe functions in attention deficit disorder with and without hyperactivity: A review and research report
5. Comparison of effects of L-Dopa, amphetamine, and apomorphine on firing rate of rat dopaminergic neurons
6. Dopaminergic neurons: Effect of antipsychotic drugs and amphetamine on single cell activity
7. Toward a pathophysiology of attention-deficit/hyperactivity disorder
8. Neuroimaging studies of ADHD
9. Cerebrospinal fluid monoamine metabolites in boys with attention-deficit hyperactivity disorder
10. Cerebrospinal homovanillic acid predicts behavioral response to stimulants in 45 boys with attention-deficit/hyperactivity disorder
11. Role of monoamine pathways in the control of attention: Effects of droperidol and methylphenidate in normal adult humans
12. Rating scales for use in drug studies with children
13. Methylphenidate and information processing. Part I: Differentiation between responders and nonresponders; Part 2: Efficacy in responders
14. The cognitive pharmacology of stimulants in children with ADHD
15. Rate-dependency of the behavioral effects of amphetamine
16. Dopamine transporter density in patients with attention deficit hyperactivity disorder
17. Cognitive control processes in attention-deficit/hyperactivity disorder
18. Effects of methylphenidate on spatial working memory and planning in healthy young adults
19. DOPA decarboxylase activity in attention deficit disorder adults. A [fluorine-18] fluorodopa positron emission tomographic study
20. High midbrain 18F-DOPA accumulation in children with ADHD
21. Comparative effects of methylphenidate and thioridazine in hyperkinetic children
22. Mathematics underlying the rate-dependency hypothesis
23. Psychostimulant actions on dopamine and limbic system function: Relevance to the pathophysiology and treatment of ADHD
24. Clinical effects of stimulants in ADHD
25. Neuronal actions of amphetamine in the rat brain
26. 2 dopamine receptors
27. Opposite effect of illumination and d-amphetamine upon activity in the squirrel monkey (Saimiri) and owl monkey (Aotes)
28. The effects of age and illumination on the dose-response curves for three stimulants
29. Executive function and attention deficit hyperactivity disorder: Stimulant medication and better executive function performance in children
30. Strain differences in amphetamine sensitivity in mice
31. Cognitive event-related potentials in attention deficit disorder
32. Stimulant drugs and vigilance performance: A review
33. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography
34. DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents
35. Attention-deficit hyperactivity disorder: A category or a continuum?
36. The action of stimulant medication in attention deficit disorder with hyperactivity: Dopaminergic, noradrenergic, or both?
37. Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: A meta-analytic review
38. Dextroamphetamine enhances 'neural network-specific' physiological signals: A positron-emission tomography rCBF study
39. Performance of disturbed hyperactive and nonhyperactive children on an objective measure of hyperactivity
40. Differential expression of autoreceptors in the ascending dopamine systems of the human brain
41. Comparative psychopharmacology of methylphenidate and related drugs in human volunteers, patients w/ ADHD and experimental animals
42. Evaluation of ADHD typology in three contrasting samples: A latent class approach
43. Exploratory activity: Genetic analysis of its modification by scopolamine and amphetamine
44. A comparison of Ritalin and Adderall: Efficacy and time-course in children with attention-deficit/hyperactivity disorder
45. A naturalistic assessment of the motor activity of hyperactive boys II. Stimulant drug effects
46. A naturalistic assessment of the motor activity of hyperactive boys I. Comparison with normal controls
47. Dextroamphetamine: Cognitive and behavioral effects in normal prepubertal boys
48. Dextroamphetamine: Cognitive and behavioral effects in normal and hyperactive boys and normal men
49. Comparing classroom and clinic measures of attention deficit disorder: Differential idiosyncratic, and dose-response effects of methylphenidate
50. Paradoxical' effects of psychomotor stimulant drugs in hyperactive children from the standpoint of behavioural pharmacology
51. Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: A study with functional MRI
52. Drugs used in the treatment of ADHD affect postsynaptic firing rate and oscillation without preferential dopamine autoreceptor
53. Are hyperactive children deficient in attentional capacity?
54. Behavioral effects of low-dose methylphenidate in childhood attention deficit disorder: Implications for a mechanism of stimulant drug action
55. The effects of reinforcement and response-cost on a delayed response task in children with attention deficit hyperactivity disorder: A research note
56. Neuropsychopharmacological mechanisms of stimulant drug action in attention deficit/hyperactivity disorder: A review and integration
57. The ecological validity of delay aversion and response inhibition as measures of impulsivity in AD/HD: A supplement to the NIMH Multi-Modal Treatment Study of AD/HD
58. A dose-response and time-action analysis of autonomic and behavioral effects of methylphenidate in attention deficit disorder with hyperactivity
59. Hyperactivity and delay aversion I. The effects of delay on choice
60. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle
61. Experimental neuropsychological studies of frontal lobe functions
62. Pharmacokinetic and pharmacodynamic properties of methylphenidate in humans
63. What do psychopharmacological studies tell us about information processing deficits in ADD/Hyperactive children?
64. Time response analysis of the effect of stimulant medication on learning ability of children referred for hyperactivity
65. Differential effects of methylphenidate on working memory in ADHD children with and without comorbid anxiety
66. Stimulant drugs on striatal and cortical dopamine systems involved in reward-related behavior and impulsivity
67. Objective measurement of hyperactivity and attentional problems in ADHD
68. Asymmetric neural control systems in human self-regulation
69. Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study
70. The role of attention
71. Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain
72. Effects of methylphenidate on regional brain glucose metabolism in humans: Relationship to dopamine D2 receptors
73. Combination of neuroleptic and stimulant treatment in attention deficit disorder with hyperactivity
74. Neurobiology of attention deficit disorder with hyperactivity: Where have we come in 50 years?